Who is taking the lead in the development of drugs for Alzheimer’s Disease?
As of today, there are no drugs that can cure Alzheimer’s: every 65 seconds someone in the US develops the disease. Alzheimer’s disease, is now the second leading cause of death in Australians.
Take a look at the current innovation landscape of drugs and treatments for Alzheimer's, and find out who is most likely to take the lead of this billion-dollar market.
What you will learn in this webinar:
- The global IP landscape of technologies related to treating and diagnosing Alzheimer’s
- How to use legal status information to evaluate the current value of Alzheimer’s-related IP
- The importance of ownership data for identifying the strongest patent portfolios
- Use of smart analytics vs. patent activity statistics